| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ERM.09.43 |
| P698 | PubMed publication ID | 19732005 |
| P2093 | author name string | Laird G Jackson | |
| Sinuhe Hahn | |||
| Mahesh Choolani | |||
| Varaprasad Kolla | |||
| Aniza P Mahyuddin | |||
| P2860 | cites work | Nanoliter scale PCR with TaqMan detection | Q24544717 |
| Inability to detect cell free fetal DNA in the urine of normal pregnant women nor in those affected by preeclampsia associated HELLP syndrome | Q38347083 | ||
| Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization. | Q38439118 | ||
| Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients | Q39877158 | ||
| Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling | Q43073656 | ||
| Methylated DNA immunoprecipitation (MeDIP). | Q46261717 | ||
| Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients | Q46448121 | ||
| Solving the "world-to-chip" interface problem with a microfluidic matrix | Q46449482 | ||
| The chromatin of differentiating erythroblasts is cleaved into large size fragments independent of caspase activated DNase and apoptosis inducing factor | Q47289021 | ||
| Cell-free DNA in maternal plasma: is it all a question of size? | Q47313732 | ||
| Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma | Q47391690 | ||
| Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma--case report | Q47399906 | ||
| Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms | Q47423342 | ||
| Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy | Q48509903 | ||
| Detection of aneuploidy with digital polymerase chain reaction | Q48567144 | ||
| Fetal cells in maternal blood: current and future perspectives. | Q50876400 | ||
| Optimization of transrenal DNA analysis: detection of fetal DNA in maternal urine. | Q51659716 | ||
| Presence of donor-derived DNA and cells in the urine of sex-mismatched hematopoietic stem cell transplant recipients: implication for the transrenal hypothesis. | Q51676207 | ||
| Characterization of first trimester fetal erythroblasts for non-invasive prenatal diagnosis. | Q52107671 | ||
| Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies. | Q53534177 | ||
| First trimester prenatal diagnosis of trisomy 21 in fetal cells from maternal blood | Q53751217 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Systematic Search for Placental DNA-Methylation Markers on Chromosome 21: Toward a Maternal Plasma-Based Epigenetic Test for Fetal Trisomy 21 | Q58029321 | ||
| Noninvasive Prenatal Detection of Fetal Trisomy 18 by Epigenetic Allelic Ratio Analysis in Maternal Plasma: Theoretical and Empirical Considerations | Q58029492 | ||
| Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 | ||
| Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting | Q24598225 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Digital PCR | Q24685020 | ||
| Transfer of fetal cells with multilineage potential to maternal tissue | Q28270559 | ||
| Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. | Q30704921 | ||
| Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study | Q31033088 | ||
| Detection and relocation of rare events. A comparative study using the laser scanning cytometer and the Metafer/RCDetect microscope scanning system. | Q31116528 | ||
| Fetal nucleated red blood cells in peripheral blood of pregnant women: detection and determination of location on a slide using laser-scanning cytometry | Q33188550 | ||
| New aspects of laser microdissection in research and routine | Q33212576 | ||
| Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation | Q33257556 | ||
| Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay | Q33265858 | ||
| Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyperoxia induces p21 in peri-infarct myocytes | Q33266095 | ||
| Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | Q33268343 | ||
| Isolating cells from non-sperm cellular mixtures using the PALM microlaser micro dissection system | Q33282813 | ||
| Noninvasive prenatal diagnosis of beta-thalassaemia using individual fetal erythroblasts isolated from maternal blood after enrichment. | Q33305250 | ||
| Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope | Q33358010 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy | Q34332473 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions | Q34540801 | ||
| Twenty-year trends in prevalence and survival of Down syndrome | Q34593738 | ||
| Digital PCR: a powerful new tool for noninvasive prenatal diagnosis? | Q34878255 | ||
| Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: what is currently feasible? | Q34949271 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women | Q35786191 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Digital quantification of mutant DNA in cancer patients. | Q36667676 | ||
| Prenatal diagnosis: progress through plasma nucleic acids | Q36673937 | ||
| Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. | Q36990581 | ||
| Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma | Q37000915 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Recent progress in non-invasive prenatal diagnosis | Q37061299 | ||
| P433 | issue | 6 | |
| P921 | main subject | diagnosis | Q16644043 |
| P304 | page(s) | 613-621 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare | Q15756305 |
| P1476 | title | Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies | |
| P478 | volume | 9 |
| Q37690454 | Circulating nucleic acids in cancer and pregnancy |
| Q36008206 | Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation |
| Q34921561 | Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? |
| Q42771985 | Getting to know the fetal genome non-invasively: now a reality |
| Q38088416 | Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges |
| Q35577099 | Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake |
| Q39850180 | Prenatal diagnosis of fetal aneuploidies: post-genomic developments |
| Q38099617 | The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made |
| Q34277946 | Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification |
| Q33538996 | Using population-based data to predict the impact of introducing noninvasive prenatal diagnosis for Down syndrome. |
| Q38209384 | What does next-generation sequencing mean for prenatal diagnosis? |
Search more.